|
|
|||
| |||||||||||||||||||||||||||||||
Pancreatic cancer has remained an enigma in an age in which great strides have been made in the management of many forms of cancer. The overall morbidity and mortality associated with pancreatic cancer are nearly the same as those presented in textbooks 25 years ago. The only substantial improvement has been the decrease in treatment-related morbidity and mortality. Our overall knowledge of the natural history of pancreatic carcinoma has also changed very little. Pancreatic cancer remains highly prevalent in western society and continues to be an intriguing and challenging problem that clinicians face on a regular basis.
Reber and associates
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |